Research Documentation

Comprehensive documentation of our research methodology and findings

About This Documentation

This documentation provides a chronological overview of our research project, methodology, and key findings. For detailed experimental protocols, raw data, and day-to-day research activities, please refer to ourLab Notebookwhich contains comprehensive records of all procedures and results.

INTRODUCTION

Project Overview

Our team of 10 STEM students from diverse backgrounds has come together to investigate protein expression optimization in both yeast and E. coli systems. We're focusing on comparing these expression systems to determine the most efficient approach for producing functional proteins.

Research Focus

  • Protein expression optimization
  • Comparative analysis of expression systems
  • Implications for neuroinflammatory research

Key Objectives

  • Evaluate expression efficiency
  • Compare system advantages
  • Optimize protocols

Research Background & Motivation

Alzheimer's disease is a major cause of cognitive decline in the U.S. with few effective treatments. We were inspired by a CSU professor's research on inflammation using nanoligamers.

Citation

Sharma, N., et al. (2024). "Novel nanoligamer approach for targeting neuroinflammation in Alzheimer's disease." Journal of Neuroinflammation, 21(1), 182-195.

View original research

Our original goal was to use yeast to mimic the nanoligamer approach. However, we learned that nanoligamers are custom-made by a Colorado company and Saccharomyces cerevisiae cannot produce them. This led us to focus on the broader inflammasome system and the proteins that build up with aging, contributing to neurodegenerative diseases.

PROJECT PROGRESS

Research Journey

Project Progress Overview

65% Complete

Planning

Prep

Execution

Analysis

Publication

We are currently in the Experimental Work phase, focusing on optimizing protein expression in E. coli while developing strategies for yeast expression systems.

Phase 1:Team Formation & Ideation
Formed team, established trust, and developed research questions.
Completed
Phase 2:Project Proposal & Funding
Developed formal project plan and secured funding.
Completed
Phase 3:Research Preparation & Literature Review
Reviewed literature, consulted faculty, and prepared lab protocols.
Completed
Phase 4:Experimental Work
Conducting experiments with E. coli and yeast expression systems.
In Progress

Plasmid Design & Preparation

  • Designed and ordered the plasmid for E. coli transformation.
  • Conducted transformation procedures and verified plasmid integrity.
  • Successfully isolated plasmid DNA using mini-prep protocols.

Yeast Expression Trials

  • Attempted subcloning into a yeast vector (pRS423-GAL).
  • Encountered issues with restriction sites and had to reassess the cloning strategy.
  • Pivoted to a new approach using Gibson Assembly to correct enzyme selection errors.

Ongoing Lab Work

  • Actively conducting transformation experiments and expression analysis.
  • Troubleshooting unexpected challenges in cloning and protein expression.
  • Optimizing protocols based on preliminary results and faculty feedback.
Protein sample in a test tube during experimental work

Protein sample preparation during experimental work

Strategic Pivot

Due to challenges with restriction enzyme compatibility, we made a strategic decision to focus on E. coli expression for our immediate MURALS presentation, while developing a Gibson Assembly approach for the yeast system to be presented at the later CURC symposium.

Phase 5:Final Presentation & Dissemination
Present findings at research symposiums and document results.
Upcoming

Next Steps

Upcoming Milestones

  • Complete Gibson Assembly for yeast expression system
  • Conduct comparative analysis between E. coli and yeast expression
  • Prepare findings for MURALS presentation
View Future Directions
EXPERIMENTAL METHODS

Plasmid System Design

E. coli Plasmid (pPOP2-E)

  • A high-copy, Ampicillin-resistant plasmid containing the human POP2 gene.
  • Features a T7 promoter for strong, inducible expression.
  • Includes a 6xHis tag for purification and detection.
  • Contains optimized restriction sites for subcloning.

Yeast Plasmid (pRS423-GAL)

  • Designed for expression in Saccharomyces cerevisiae.
  • Contains the GAL promoter for galactose-inducible expression.
  • Includes a HIS3 selectable marker for maintenance in auxotrophic strains.
  • Features a 2μ origin for high-copy maintenance.

E. coli Expression Plasmid Map

POP2 E. coli Expression Plasmid Map showing T7 promoter, POP2_3xFlag gene, and other genetic elements

Figure 1: Circular map of the POP2 E. coli expression plasmid (5943 bp) showing key genetic elements including T7 promoter, POP2_3xFlag gene, Lac operator, and ampicillin resistance marker.

Zoom:100%

Transformation Protocols

E. coli Transformation

We used a standard heat-shock transformation protocol to introduce our plasmid into competent E. coli cells.

Key Protocol Steps:

  1. Thaw competent cells on ice (30-60 minutes)
  2. Add plasmid DNA (1 μL) to competent cells (20 μL)
  3. Incubate on ice for 30 minutes
  4. Heat-shock at 42°C for exactly 30 seconds
  5. Add SOC media (219 μL) and recover at 37°C for 1 hour with shaking
  6. Plate on selective media (LB + Ampicillin) and incubate overnight

For complete protocol details and daily experimental logs, refer to our lab notebook.

View in Lab Notebook

Restriction Digest Issues
Unsuccessful

Gel Electrophoresis Results

Our restriction enzyme digest analysis revealed unexpected cutting patterns, which confirmed our suspicions about the restriction sites. The gel electrophoresis results below show the unexpected bands that indicated we had cut the GAL promoter in pRS423-GAL instead of the intended target.

Gel Electrophoresis Results

Placeholder for gel electrophoresis visualization.

Alternative Cloning Strategy: Gibson Assembly

After encountering issues with restriction enzyme compatibility, we developed an alternative cloning strategy using Gibson Assembly. This method allows for seamless assembly of DNA fragments without relying on specific restriction sites.

POP2 Gibson Assembly plasmid map showing the assembly of DNA fragments with overlapping ends

Figure 2: Circular map of the POP2 Gibson Assembly construct (7055 bp) showing the seamless assembly of DNA fragments. Key features include the 2μ origin for yeast replication, HIS3 marker, and the POP2_3xFlag gene with Gibson assembly junctions.

Zoom:100%

The Gibson Assembly approach allowed us to overcome the restriction site incompatibilities by using overlapping DNA fragments that can be joined seamlessly in a single isothermal reaction. This method is more flexible and efficient for complex cloning projects.

Key Issues Identified:

  • The XhoI site in pRS423-GAL was located within the GAL promoter, meaning digestion would disrupt the promoter functionality.
  • Alternative restriction sites (NotI with SacII) were explored, but SacII requires a specific coenzyme for optimal activity that was not available in our lab.
  • We discovered that we had mistakenly ordered enzymes that were incompatible with our cloning strategy.

This setback led to our strategic pivot to focus on E. coli expression while developing an alternative approach for yeast.

View Full Protocol

Expression Optimization

Temperature Effects on Expression

We conducted temperature optimization experiments for E. coli expression, testing three biologically relevant temperatures:

30°C

Optimal for yeast growth

75% Expression Efficiency

  • Slower growth (~5.5 hours to induction)
  • Better protein folding quality

37°C

Optimal for E. coli

90% Expression Efficiency

  • Faster growth (~4 hours to induction)
  • Highest overall protein yield

40°C

Human fever temperature

45% Expression Efficiency

  • Similar growth rate to 37°C
  • Reduced protein stability

For complete temperature optimization data and growth curves, explore our interactive data dashboard.

RESULTS & ANALYSIS

Key Findings

Summary of Results

E. coli Expression System

  • Successfully transformed and isolated pPOP2-E plasmid with high yield
  • Optimized expression conditions at 37°C with 5-hour post-induction incubation
  • Achieved consistent protein expression with minimal degradation
  • Determined that 40°C significantly reduced protein yield despite similar growth kinetics

Cloning Strategy Refinement

  • Identified critical restriction site incompatibilities through gel electrophoresis
  • Developed alternative Gibson Assembly approach for yeast expression system
  • Created a more robust cloning workflow that avoids restriction enzyme limitations

Methodological Insights

  • Demonstrated the importance of thorough restriction site analysis before ordering plasmids
  • Established optimal temperature conditions for POP2 expression in prokaryotic systems
  • Developed a framework for comparative expression system analysis

Interactive Data Exploration

Our research generated extensive data on protein expression kinetics, temperature effects, and structural analysis. Explore our interactive data visualizations to gain deeper insights into our findings.

Expression Kinetics

Time-course analysis of protein expression in E. coli and yeast systems.

Explore Data

Temperature Effects

Impact of temperature on expression efficiency in both systems.

Explore Data

Protein Structure

Interactive 3D visualization of the human POP2 protein structure.

Explore Structure

Plasmid Maps

Detailed maps of our E. coli expression and Gibson Assembly plasmids.

View Maps

Future Directions

Short-term Goals

  • Complete Gibson Assembly for yeast expression system
  • Conduct direct comparison of protein yield and quality between E. coli and yeast systems
  • Analyze post-translational modifications in yeast-expressed POP2

Long-term Research Potential

  • Explore functional activity of POP2 in inflammasome regulation
  • Investigate potential therapeutic applications for neurodegenerative diseases
  • Develop optimized expression systems for other inflammasome-related proteins

Methodological Improvements

  • Implement more comprehensive documentation of buffer compositions and incubation conditions
  • Develop standardized protocols for comparative expression system analysis
  • Establish quantitative metrics for protein quality assessment
  • Expand Gibson Assembly applications for more complex constructs, building on our successful implementation for the yeast expression system
TEAM

Our Research Team

The POP2 Research Team

Team Overview

Our team consists of 10 STEM students from diverse backgrounds, including biology, fermentation science, computer science, data science, mathematics, and economics. This interdisciplinary approach allowed us to tackle complex research challenges from multiple perspectives.

Project Leadership

Jacob Leavitt served as the driving force behind this project, coordinating team efforts, facilitating communication between team members and faculty advisors, and ensuring that the project stayed on track despite numerous challenges. His leadership was instrumental in the successful execution of this research.

Team Members

  • Jacob Leavitt - Project coordinator and team leader who organized, guided, and supported the team throughout the entire research process.
  • Van Mai - Biomedical sciences with a focus on neurodegenerative diseases.
  • Mia Papantonio - Hands-on lab researcher for experimental work.
  • Kaitlyn Manzanares - Strong technical skills in both lab work and data analysis.
  • Mia Krause - Physics and math expertise for experimental design.
  • Edward Lue Chee Lip - Environmental research focusing on water quality.
  • Elena Tran - Engages in lab-based research in environmental sciences.
  • Aryan Advaita - Computer science expert focused on simulations and modeling.
  • Chloe Alivio - Mathematics specialist handling data analysis and statistics.
  • Sol Rivera - Specializes in biotechnology and neurodegenerative diseases.
  • Shahina Abdullayeva - Economics background providing project management support.

Faculty Advisors

  • Dr. Victor Kasper - Facilitator who helped the team access resources and navigate project challenges.
  • Dr. Stephanie Moreira (Mo) - Facilitator providing guidance and resource support.
  • Dr. Grant Schauer - Assistant Professor who donated a plasmid, offered lectures, and provided key advice.
  • Dr. Cathy Radebaugh - Assistant Professor who granted lab access, shared advice, and supported project pivots.
  • Dr. Sarah Swygert - Assistant Professor who contributed expertise and critical insights.